The 3rd Lifecycle Management for Combination Products Summit
Lifecycle management for drug-device combination products has stolen the spotlight amongst pharma, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is serious potential and benefits of having such a mind-set and implementing a robust LCM program from the get-go.
As the only peer-led community, 100+ senior leaders from drug-device teams, including regulatory affairs, product development and quality, will met this June to share their view and encourage collaborative efforts.
In 2020, the 3rd Life Cycle Management for Combination Products summit will return to discuss LCM and design control, emphasising the implication of the EU MDR, post-market surveillance and how to manage design and change control to maintain market dominance.
Download the Full Event Guide to see how this meeting can maximize your combination products’ lifespan and continue to deliver a quality drug-device product for your patients in 2020.